BIO International 2026: Twenty Years After FDA’s Exploratory IND Guidance: Is the Time Finally Right for Exploratory Development of Therapeutic Antibodies and Recombinant Proteins?
Experience.
History-Making.
What’s the Buzz?! Episode Recording
What’s the Buzz?! | BioFlorida and the Regenerative Medicine Bloom
GBI Biomanufacturing Appoints Chandra Kelley as Chief Business Officer
‘Demand is growing:’ Plantation lab ramps up stem-cell production
Longtime biotech company expands Broward County facility
Stem Cell Opportunities Expand-and so does GBI
‘Right to Try’ Laws Place Stem Cells Front and Center in Regenerative Pain Medicine
Local biotech to expand stem cell production as Florida law opens new market
